Literature DB >> 15106032

Comparison of different methods for the measurement of serum testosterone in the aging male.

M Christ-Crain1, C Meier, P Huber, L Zimmerli, M Trummler, B Müller.   

Abstract

BACKGROUND: Circulating testosterone (T) levels, mainly non-SHBG bound fractions, decline with advancing age. Free (FT) and bioavailable (BT) testosterone levels have been suggested to represent more reliably the bioactive hormone at the tissue level as compared to total testosterone (TT) levels. However, there is an ongoing controversy as to which T assay is most appropriate in defining T deficiency in the aging male.
METHODS: In a prospective observational study, TT, FT and BT levels were measured in 51 elderly men (55 to 70 years). TT levels were determined on two different days using 2 different assays. FT was calculated using TT, albumin and SHBG levels as well as measured directly by radioimmunoassay. The free androgen index (FAI) was calculated using the formula 100 x TT/SHBG. BT was obtained by precipitation of SHBG-bound T with ammonium sulphate.
RESULTS: We found good correlations within different assays for TT (r = 0.87 to 0.91, p <0.001) and between TT and calculated FT (r = 0.66 to 0.84, p <0.001). In contrast, the correlation between TT and BT was poor (r = 0.17 to 0.19, p = ns). TT was equivalent to calcFT and was better in mirroring clinical sings of androgen deficiency in elderly men as compared to BT. The intra-individual day-to-day variance of TT levels was 14.8% (range 0.1-79%) with a coefficient of variance of 12.6%.
CONCLUSION: Serum TT and the calculated FT fraction correlated well with each other and were superior in defining a group of elderly men with suspected androgen deficiency. In contrast, FT measured by direct RIA and BT reflected gonadal function poorly. Our data favour the repetitive use of TT when screening for androgen deficiency in elderly men.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15106032     DOI: 2004/13/smw-10559

Source DB:  PubMed          Journal:  Swiss Med Wkly        ISSN: 0036-7672            Impact factor:   2.193


  5 in total

1.  Androgen levels in older men who have or who are at risk of acquiring HIV infection.

Authors:  Robert S Klein; Yungtai Lo; Nanette Santoro; Adrian S Dobs
Journal:  Clin Infect Dis       Date:  2005-11-11       Impact factor: 9.079

2.  Higher serum testosterone is associated with increased risk of advanced hepatitis C-related liver disease in males.

Authors:  Donna L White; Shariar Tavakoli-Tabasi; Jill Kuzniarek; Rhia Pascua; David J Ramsey; Hashem B El-Serag
Journal:  Hepatology       Date:  2011-12-14       Impact factor: 17.425

3.  Calculated free testosterone and radioimmunoassay free testosterone as a predictor of subnormal levels of total testosterone.

Authors:  Graziele Halmenschlager; Ernani Luis Rhoden; Charles Edison Riedner
Journal:  Int Urol Nephrol       Date:  2011-10-14       Impact factor: 2.370

4.  Genome-wide association study with 1000 genomes imputation identifies signals for nine sex hormone-related phenotypes.

Authors:  Katherine S Ruth; Purdey J Campbell; Shelby Chew; Ee Mun Lim; Narelle Hadlow; Bronwyn G A Stuckey; Suzanne J Brown; Bjarke Feenstra; John Joseph; Gabriela L Surdulescu; Hou Feng Zheng; J Brent Richards; Anna Murray; Tim D Spector; Scott G Wilson; John R B Perry
Journal:  Eur J Hum Genet       Date:  2015-05-27       Impact factor: 4.246

5.  Persistent bone impairment despite long-term control of hyperprolactinemia and hypogonadism in men and women with prolactinomas.

Authors:  Lukas Andereggen; Janine Frey; Robert H Andres; Markus M Luedi; Hans Rudolf Widmer; Jürgen Beck; Luigi Mariani; Emanuel Christ
Journal:  Sci Rep       Date:  2021-03-04       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.